HOME >> MEDICINE >> NEWS
Tourettes, other tic disorders far more common than once thought

One out of four students in special-education classes has a tic-related disorder like Tourette syndrome, and the rate of Tourettes among students in the general population is 50 to 75 times higher than has been traditionally thought by doctors, according to a study published in the Oct. 23 issue of the journal Neurology.

The neurologists who did the study say that Tourettes comes in many forms, including variations much milder than the profanity-spewing, limb-jerking characters seen on TV shows like Ally McBeal and LA Law. Doctors say the findings should raise awareness among teachers and doctors that children who are performing poorly in school and who have tics may need medical treatment, and that such treatment could ease school difficulties for these students.

Most people view Tourettes as a very rare, unusual disorder with bizarre symptoms, but its really very common, usually with mild symptoms, says Roger Kurlan, M.D., a professor of neurology at the University of Rochester Medical Center and lead author of the Neurology paper. The cases you see on TV are the most severe cases, and theyre just the tip of the iceberg. Most cases of Tourettes are much milder and dont progress to the severe form.

In the study of 1,596 children in Rochester, N.Y., 8 percent of children in special education met the criteria for Tourettes, and about 27 percent had some tic disorder. In the general population, 3 percent had Tourettes, and 20 percent had a tic disorder. The rate of 3 percent in the general population is about 50 to 75 times higher than typical estimates.

While tics like barking obscenities or jerking ones head are easy to spot, there are a slew of other repetitive and involuntary movements or vocalizations tics that are usually overlooked by family, friends and co-workers as strange or annoying habits, Kurlan says. Common tics include rapid eye-blinking, scrunching up ones nose, little jerks of the head, facial twitches,
'"/>

Contact: Tom Rickey
trickey@admin.rochester.edu
716-275-7954
University of Rochester Medical Center
31-Oct-2001


Page: 1 2 3 4

Related medicine news :

1. Hausman to give keynote address at Breastfeeding, Motherhood and Feminism symposium
2. Do minorities survive hospitalization better than others?
3. Mental health service costs offset by savings in other public sectors
4. Single mothers at higher risk for depression
5. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds
6. Rhesus monkeys reason about perspectives of others in obtaining food
7. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer
8. Forensic dentistry key in identifying victims of tsunamis, other disasters
9. Nursing mothers having surgery -- How long a wait to breastfeed safely?
10. New guideline tackles leading cause of mother and child death
11. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Tourettes other tic disorders far more common than once thought

(Date:6/29/2015)... CA (PRWEB) , ... June 29, 2015 , ... ... and imprinted accessories, is offering discounted pricing on all purchases that include branding. ... foundation of a brand is the logo. The website, packaging and promotional materials, all ...
(Date:6/29/2015)... VA (PRWEB) , ... June 29, 2015 , ... ... services to government contractors, nonprofits, independent schools, and other growing businesses across the ... Insights Top 100 Value Added Resellers for the fifth consecutive year. , Based ...
(Date:6/29/2015)... ... June 29, 2015 , ... Human Factors and Usability Studies: ... 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/humanfactors , The ... to the design of new products as well as to postmarket surveillance of ...
(Date:6/29/2015)... , ... June 29, 2015 , ... People across the country give their coworkers and ... part of our culture. , But, how often do coworkers donate “life” to the ... a simple one. , “Dawna (Wright-Thompson) told me her husband was on a ...
(Date:6/29/2015)... ... June 29, 2015 , ... Two ... against C.R. Bard, Inc. and Ethicon, Inc. continue to move forward in New ... Management Conference is to be convened on Thursday, July 23rd at 12:00 p.m. ...
Breaking Medicine News(10 mins):Health News:Stock Up on Logo Branding Tools Reduced this Month and Next Month from Displays and Exhibits 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 3Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 2Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 3Health News:VA Pittsburgh Employee Donates Kidney to Coworker’s Spouse 2Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 2Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 3Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 4
(Date:6/29/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a developer ... is now included in the Russell 3000®, the Russell ... to the indexes occurred at the close of trading ... its comprehensive set of U.S. and global indexes. ... Cap and Global Indexes coincides with the progress we ...
(Date:6/29/2015)... , June 29, 2015  Relmada Therapeutics, ... therapies for the treatment of chronic pain, announced ... study with novel formulations of oral, enteric-coated buprenorphine ... chronic pain and opioid dependence indications has reached ... company anticipates reporting top-line results in the second ...
(Date:6/29/2015)... England , June 29, 2015  Eli ... Immunocore Limited today announced that they have entered ... the utility of Immunocore,s lead T cell receptor-based ... (LY2157299) and merestinib (LY2801653) for the treatment of ... identify combination regimens that provide synergies in efficacy ...
Breaking Medicine Technology:Trovagene Upgraded to Russell 3000, Small Cap and Global Indexes 2Trovagene Upgraded to Russell 3000, Small Cap and Global Indexes 3Enrollment in Relmada Therapeutics' Proof-of-Concept Clinical Study for Novel Oral Formulations of Buprenorphine Reaches Halfway Mark 2Enrollment in Relmada Therapeutics' Proof-of-Concept Clinical Study for Novel Oral Formulations of Buprenorphine Reaches Halfway Mark 3Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 2Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 3Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 4Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 5Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 6Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 7
Cached News: